CPT code 62269 represents a needle biopsy of the spinal cord performed to obtain tissue for diagnostic evaluation. This invasive diagnostic procedure is clinically significant for definitive diagnosis of intramedullary spinal lesions when imaging and less invasive sampling are inconclusive. Nationally, accurate coding and documentation for spinal cord biopsy affect care pathways, perioperative planning, and appropriate utilization of high-acuity resources.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and payer coverage considerations. The publication also outlines common billing modifiers and provides guidance on what information is typically necessary for claims adjudication. Policy updates and benchmarking content are summarized to help stakeholders understand reimbursement patterns and documentation expectations across major payers.

The article is designed for coding professionals, hospital billing teams, neurosurgeons, and compliance officers seeking a national view of how CPT code 62269 is used, what clinical scenarios prompt its use, and what documentation elements support appropriate billing. Data not available in the input will be noted where relevant.